BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Sep 30, 2024 | (Q3)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q9)Dec 31, 2023 | (Q6)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q3)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 34.22%786.18M | 37.20%313M | -36.07%1.37B | -47.31%1.06B | -58.18%585.75M | -66.96%228.13M | -22.83%2.14B | -10.77%2.01B | 0.59%1.4B | 6.20%690.51M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 33.15%-55.15M | 34.27%-26.41M | -4.56%-148.13M | -19.42%-117.52M | -46.63%-82.5M | -115.12%-40.17M | -150.92%-141.67M | -161.13%-98.41M | -142.25%-56.26M | -105.76%-18.68M |
Dividend (income)- adjustment | -163.09%-1.96M | -4.70%-691K | -5.43%-2.93M | 66.90%-1.32M | 55.04%-745K | 45.72%-660K | 35.08%-2.78M | -23.54%-3.97M | -22.74%-1.66M | -186.12%-1.22M |
Attributable subsidiary (profit) loss | 11.59%14.53M | 59.79%7.5M | 52.74%25.66M | 41.81%15.49M | 50.95%13.02M | -7.51%4.7M | 143.04%16.8M | 184.87%10.92M | 176.56%8.63M | 386.67%5.08M |
Impairment and provisions: | --67.05M | --47.05M | 5,141.23%46.91M | ---- | ---- | ---- | -97.85%895K | ---- | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | --10.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | --67.05M | --47.05M | 3,970.95%36.44M | ---- | ---- | ---- | -97.15%895K | ---- | ---- | ---- |
Revaluation surplus: | 88.94%-11.26M | 78.36%-15.26M | 37.55%-153.87M | 38.41%-95.37M | 23.35%-101.83M | 39.59%-70.54M | -378.66%-246.4M | -9.74%-154.84M | -59.58%-132.86M | 11.37%-116.77M |
-Other fair value changes | 88.94%-11.26M | 78.36%-15.26M | 37.55%-153.87M | 38.41%-95.37M | 23.35%-101.83M | 39.59%-70.54M | -378.66%-246.4M | -9.74%-154.84M | -59.58%-132.86M | 11.37%-116.77M |
Asset sale loss (gain): | -313.39%-23.47M | -761.39%-23.29M | 167.19%17.32M | 808.82%11.43M | 498.97%11M | 1,194.85%3.52M | 129.96%6.48M | 104.24%1.26M | 105.62%1.84M | 120.86%272K |
-Loss (gain) from sale of subsidiary company | ---22.63M | ---22.63M | 99.07%-12K | 98.98%-12K | ---- | ---- | 96.00%-1.29M | 96.35%-1.18M | 100.03%10K | 101.21%10K |
-Loss (gain) on sale of property, machinery and equipment | -202.15%-1.14M | -69.72%-964K | -43.84%3.48M | -324.12%-2.41M | 141.77%1.12M | -323.62%-568K | 173.51%6.2M | 136.31%1.07M | 109.34%462K | 153.03%254K |
-Loss (gain) from selling other assets | -96.95%301K | -92.74%297K | 776.71%13.85M | 915.54%13.85M | 624.34%9.88M | 51,025.00%4.09M | -81.19%1.58M | -75.48%1.36M | -70.28%1.36M | --8K |
Depreciation and amortization: | 2.07%701.54M | 1.99%346.36M | 4.47%1.41B | 2.94%1.04B | 3.37%687.33M | 2.47%339.6M | 6.98%1.35B | 8.26%1.02B | 7.18%664.91M | 7.84%331.4M |
-Amortization of intangible assets | 4.95%423.68M | 6.89%210.11M | 1.07%832.78M | -1.57%620.39M | -2.72%403.69M | -4.16%196.58M | 5.25%823.94M | 7.63%630.29M | 7.27%414.99M | 8.17%205.11M |
Financial expense | 3.02%399.51M | 1.49%200.38M | 15.98%762.81M | 22.22%562.26M | 40.90%387.8M | 96.77%197.43M | 81.49%657.7M | 65.44%460.05M | 47.13%275.24M | -0.24%100.34M |
Special items | -6.94%138.74M | -9.86%61.87M | -59.83%134.14M | -5.23%228.85M | -6.12%149.09M | -7.95%68.63M | -9.47%333.98M | -9.76%241.49M | -8.52%158.81M | -21.86%74.56M |
Operating profit before the change of operating capital | 22.24%2.02B | 24.62%910.5M | -15.88%3.46B | -22.19%2.71B | -28.90%1.65B | -31.43%730.63M | -12.06%4.11B | -2.45%3.48B | 1.82%2.32B | 2.73%1.07B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -1,406.73%-2.44B | -339.59%-1.09B | -119.23%-360.69M | -82.48%133.88M | 248.79%186.54M | 179.90%453.05M | 197.45%1.88B | 136.98%764.07M | 94.67%-125.37M | 60.90%-567.01M |
Accounts receivable (increase)decrease | -123.25%-2.52B | -193.43%-393.39M | -104.05%-190.93M | -140.24%-1.36B | -135.95%-1.13B | 6.44%421.06M | 268.82%4.72B | 174.59%3.38B | 352.40%3.14B | 165.07%395.6M |
Accounts payable increase (decrease) | 469.80%5.41B | 358.69%1.73B | 105.88%401.08M | 117.94%797.05M | 135.46%948.77M | -74.28%-667.74M | -234.16%-6.82B | -169.70%-4.44B | -170.78%-2.68B | -122.07%-383.14M |
Special items for working capital changes | -187.28%-137.86M | -156.16%-67.46M | 20.13%58.97M | 172.38%135.53M | -32.11%157.96M | 40.12%120.12M | -37.48%49.09M | 566.10%49.76M | 1,757.91%232.69M | 211.52%85.73M |
Cash from business operations | 28.20%2.32B | 3.26%1.09B | -14.38%3.37B | -25.22%2.41B | -37.44%1.81B | 77.17%1.06B | -23.18%3.93B | -3.74%3.23B | 17.16%2.9B | -19.63%596.68M |
Other taxs | 51.50%-159.97M | 50.59%-106.96M | -16.24%-613.9M | -50.83%-396.51M | -100.10%-329.85M | -126.29%-216.45M | 27.61%-528.11M | 46.61%-262.88M | 45.70%-164.85M | 52.36%-95.65M |
Interest paid - operating | -1.66%-384.65M | -1.23%-193.26M | -22.95%-744.05M | -34.94%-548.27M | -52.44%-378.37M | -86.60%-190.91M | -91.76%-605.14M | -65.99%-406.3M | -55.14%-248.22M | -8.80%-102.31M |
Net cash from operations | 61.12%1.78B | 21.80%791.39M | -28.21%2.01B | -42.60%1.47B | -55.56%1.1B | 62.96%649.76M | -31.29%2.8B | -2.20%2.56B | 23.64%2.48B | -10.93%398.72M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -29.69%55.15M | -34.27%26.41M | 15.51%144.07M | 38.51%112.84M | 58.10%78.44M | 115.12%40.17M | 120.92%124.73M | 116.18%81.47M | 113.62%49.61M | 105.76%18.68M |
Dividend received - investment | 163.09%1.96M | 4.70%691K | 5.43%2.93M | -66.90%1.32M | -55.04%745K | -45.72%660K | -35.08%2.78M | 23.54%3.97M | 22.74%1.66M | 186.12%1.22M |
Loan receivable (increase) decrease | -81.07%5.58M | -131.67%-6.21M | 315.57%23.83M | --25.95M | --29.47M | --19.6M | ---11.05M | ---- | ---- | ---- |
Decrease in deposits (increase) | -42.06%5.32M | 28.77%3.53M | -73.73%5.61M | -85.28%4.53M | -71.42%9.18M | -92.16%2.74M | 164.45%21.35M | 333.57%30.75M | 233.01%32.13M | 249.47%34.94M |
Sale of fixed assets | -34.27%12.57M | -64.76%5.84M | -14.28%28.01M | 35.91%25.32M | 17.39%19.12M | 41.18%16.56M | 54.19%32.68M | 18.92%18.63M | 34.69%16.29M | 136.44%11.73M |
Purchase of fixed assets | -29.79%-167.55M | -31.69%-81.3M | 35.78%-275.1M | 39.41%-176.62M | 33.40%-129.09M | 33.68%-61.73M | -8.08%-428.37M | -11.43%-291.49M | -12.68%-193.84M | 4.96%-93.08M |
Purchase of intangible assets | 21.50%-243.55M | 4.24%-149.99M | -20.61%-556.12M | -38.60%-507.02M | -28.71%-310.24M | 2.11%-156.62M | -61.34%-461.08M | -40.31%-365.81M | -51.22%-241.05M | -109.98%-160M |
Sale of subsidiaries | ---14.27M | ---14.27M | --313K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | 47.78%-6.44M | ---- | 87.99%-12.38M | 87.88%-12.32M | 85.29%-12.32M | ---- | 56.42%-103.06M | -104,947.42%-101.7M | -25,683.69%-83.8M | ---298K |
Recovery of cash from investments | -67.41%32.7M | -91.25%7.91M | -45.88%124.31M | -23.40%116.26M | -8.28%100.32M | 183.99%90.4M | 95.45%229.69M | 52.35%151.76M | 254.40%109.37M | 35.18%31.83M |
Cash on investment | 54.62%-206.17M | 25.99%-112.36M | 41.99%-768.93M | 44.90%-623.37M | 48.61%-454.36M | 34.79%-151.81M | -54.05%-1.33B | -83.85%-1.13B | -144.99%-884.17M | -49.48%-232.78M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | --2.81M | --2.81M | ---- | ---- |
Net cash from investment operations | 21.54%-524.7M | -59.85%-319.75M | 32.98%-1.28B | 35.47%-1.03B | 43.98%-668.74M | 48.42%-200.03M | -27.80%-1.92B | -73.22%-1.6B | -123.15%-1.19B | -102.41%-387.77M |
Net cash before financing | 188.26%1.25B | 4.87%471.64M | -17.92%727.54M | -54.54%434.6M | -66.27%434.81M | 4,007.52%449.73M | -65.63%886.38M | -43.44%956.01M | -12.49%1.29B | -95.72%10.95M |
Cash flow from financing activities | ||||||||||
New borrowing | 162.68%6.61B | 122.24%3.15B | 7.40%11.79B | -31.12%6.73B | -65.74%2.52B | -59.87%1.42B | 6.49%10.98B | 22.08%9.77B | 24.75%7.34B | 26.01%3.53B |
Refund | -166.16%-6.64B | -123.85%-3.15B | -7.46%-11.8B | 30.88%-6.74B | 65.95%-2.49B | 59.85%-1.41B | -6.56%-10.98B | -21.90%-9.75B | -24.58%-7.33B | -25.34%-3.51B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | --675M | --675M | --675M | ---- |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | --1.25B | --1.25B | --1.25B | ---- |
Dividends paid - financing | -3.56%-491.5M | 74.61%-2.63M | -1.47%-629.14M | -2.35%-623.31M | -3.45%-474.62M | -1,193.50%-10.35M | -17.86%-620.04M | -15.76%-608.98M | -22.75%-458.81M | 85.71%-800K |
Absorb investment income | 1.68%77.76M | -83.26%462K | 349.63%112.65M | 411.36%108.22M | 580.59%76.47M | -75.44%2.76M | -86.03%25.05M | -87.84%21.16M | -72.68%11.24M | 34.77%11.24M |
Issuance expenses and redemption of securities expenses | ---- | ---- | 90.36%-132.08M | 84.22%-132.08M | 93.45%-51.28M | ---- | -131.55%-1.37B | -228.92%-837.08M | -275.95%-783.39M | ---- |
Other items of the financing business | 54.56%-167.4M | 96.02%-9.99M | -166.20%-546.68M | -598.33%-427.3M | -1,292.05%-368.39M | -2,182.94%-250.78M | 69.78%-205.37M | 80.76%-61.19M | 91.35%-26.46M | 93.18%-10.99M |
Net cash from financing operations | 21.44%-674.26M | 83.34%-47.21M | -222.91%-1.34B | -474.70%-1.18B | -239.14%-858.25M | -3,235.51%-283.39M | 76.45%-413.78M | 131.31%315.35M | 168.78%616.84M | 95.27%-8.5M |
Effect of rate | 144.56%39.95M | -18.68%-73.14M | 46.54%-81.69M | 79.81%-36.89M | 66.66%-89.66M | 57.39%-61.63M | -475.60%-152.81M | -3,686.83%-182.75M | -10,216.78%-268.9M | -564.68%-144.65M |
Net Cash | 236.77%579.13M | 155.15%424.43M | -228.77%-608.56M | -158.76%-747.03M | -122.22%-423.44M | 6,681.37%166.35M | -42.45%472.61M | 86.15%1.27B | 230.66%1.91B | -96.78%2.45M |
Begining period cash | -16.24%3.56B | -16.24%3.56B | 8.14%4.25B | 8.14%4.25B | 8.14%4.25B | 8.14%4.25B | 28.09%3.93B | 28.09%3.93B | 28.09%3.93B | 28.09%3.93B |
Cash at the end | 11.83%4.18B | -10.19%3.91B | -16.24%3.56B | -30.94%3.47B | -32.88%3.74B | 14.96%4.35B | 8.14%4.25B | 33.61%5.02B | 52.64%5.57B | 19.28%3.79B |
Cash balance analysis | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.